| BBOT |
BridgeBio Oncology Therapeutics, Inc. |
26 Aug 2025 |
1 |
$0 |
4 |
Chief Financial Officer |
28 Aug 2025, 16:34 |
| BBOT |
BridgeBio Oncology Therapeutics, Inc. |
11 Aug 2025 |
0 |
$0 |
3 |
Chief Financial Officer |
18 Aug 2025, 17:08 |
| FDMT |
4D Molecular Therapeutics, Inc. |
06 Mar 2025 |
1 |
$0 |
4 |
Chief Financial & Business Officer |
10 Mar 2025, 19:57 |
| FDMT |
4D Molecular Therapeutics, Inc. |
11 Dec 2023 |
1 |
$0 |
4 |
CHIEF FINANCIAL & BUSINESS OFFICER |
13 Dec 2023, 16:05 |
| FDMT |
4D Molecular Therapeutics, Inc. |
01 Oct 2023 |
1 |
$0 |
4 |
CHIEF FINANCIAL & BUSINESS OFFICER |
03 Oct 2023, 16:17 |
| FDMT |
4D Molecular Therapeutics, Inc. |
22 Sep 2023 |
0 |
$0 |
3 |
CHIEF FINANCIAL & BUSINESS OFFICER |
26 Sep 2023, 21:33 |
| MYOV |
Myovant Sciences Ltd. |
10 Mar 2023 |
4 |
$0 |
4 |
Principal Financial Officer |
10 Mar 2023, 08:31 |
| MYOV |
Myovant Sciences Ltd. |
16 Dec 2022 |
1 |
-$59,947 |
4 |
Principal Financial Officer |
20 Dec 2022, 19:07 |
| MYOV |
Myovant Sciences Ltd. |
16 Sep 2022 |
1 |
-$174,323 |
4 |
Principal Financial Officer |
20 Sep 2022, 16:56 |
| MYOV |
Myovant Sciences Ltd. |
15 Apr 2022 |
1 |
$0 |
4 |
Principal Financial Officer |
19 Apr 2022, 16:52 |
| MYOV |
Myovant Sciences Ltd. |
15 Sep 2021 |
2 |
$0 |
4 |
Principal Financial Officer |
17 Sep 2021, 16:31 |
| MYOV |
Myovant Sciences Ltd. |
07 Sep 2021 |
0 |
$0 |
3 |
Principal Financial Officer |
09 Sep 2021, 16:24 |